Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Su TH"" wg kryterium: Autor


Wyświetlanie 1-19 z 19
Tytuł :
Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Peng CY; School of Medicine, China Medical University, Taichung, Taiwan.; Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Feb 03; Vol. 221 (4), pp. 589-597.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antigens, Neoplasm/*blood
Carcinoma, Hepatocellular/*etiology
Hepatitis B, Chronic/*complications
Hepatitis B, Chronic/*mortality
Liver Cirrhosis/*complications
Liver Cirrhosis/*mortality
Liver Neoplasms/*etiology
Membrane Glycoproteins/*blood
Adult ; Aged ; Antiviral Agents/therapeutic use ; Biomarkers, Tumor/blood ; Female ; Glycosylation ; Hepatitis B virus ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/virology ; Humans ; Liver Cirrhosis/virology ; Male ; Middle Aged ; Prognosis ; Remission Induction ; Retrospective Studies ; Risk
Czasopismo naukowe
Tytuł :
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
Autorzy :
Yang HI; Genomics Research Center, Academia Sinica, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Yeh ML; Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wong GL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.
Peng CY; Department of Gastroenterology, China Medical University Hospital, Taichung, Taiwan.
Chen CH; Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Trinh HN; San Jose Gastroenterology, San Jose, California, USA.
Cheung KS; Department of Medicine, The University of Hong Kong, Hong Kong.
Xie Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Peopole's Republic of China.
Su TH; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Kozuka R; Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Lee DH; Department of Gastroenterology, Good Gang-An Hospital, Busan, South Korea.
Ogawa E; Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
Zhao C; Department of Cirrhosis, Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, Peopole's Republic of China.
Ning HB; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, Peopole's Republic of China.
Huang R; Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, Peopole's Republic of China.
Li J; Palo Alto Medical Foundation, Mountain View Division, Mountain View, California, USA.
Zhang JQ; Chinese Hospital, San Francisco, California, USA.
Ide T; Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan.
Xing H; Beijing Ditan Hospital, Capital Medical University, Beijing, Peopole's Republic of China.
Iwane S; Department of Internal Medicine, Saga University Hospital, Saga, Japan.
Takahashi H; Department of Internal Medicine, Saga University Hospital, Saga, Japan.
Wong C; Wong Clinics, San Francisco, California, USA.
Wong C; Wong Clinics, San Francisco, California, USA.
Lin CH; Department of Gastroenterology, China Medical University Hospital, Taichung, Taiwan.
Hoang J; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Le A; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Henry L; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Ueno Y; Department of Gastroenterology, Yamagata University, Yamagata, Japan.
Gane EJ; Liver Transplant Unit, University of Auckland, Auckland, New Zealand.
Eguchi Y; Department of Internal Medicine, Saga University Hospital, Saga, Japan.
Kurosaki M; Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan.
Wu C; Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, Peopole's Republic of China.
Liu C; Department of Cirrhosis, Institute of Liver Disease, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, Peopole's Republic of China.
Shang J; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou, Peopole's Republic of China.
Furusyo N; Department of General Internal Medicine, Kyushu University Hospital, Fukuoka, Japan.
Enomoto M; Department of Hepatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Kao JH; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yuen MF; Department of Medicine, The University of Hong Kong, Hong Kong.
Yu ML; Department of Internal Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Nguyen MH; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Palo Alto, California, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2020 Jan 14; Vol. 221 (3), pp. 389-399.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Research Design*
Antiviral Agents/*adverse effects
Antiviral Agents/*therapeutic use
Carcinoma, Hepatocellular/*etiology
Hepatitis B virus/*genetics
Hepatitis B, Chronic/*drug therapy
Liver Neoplasms/*etiology
Administration, Oral ; Adult ; Antiviral Agents/administration & dosage ; Asia/ethnology ; Asian Continental Ancestry Group ; Cohort Studies ; DNA, Viral/genetics ; Data Accuracy ; Female ; Hepatitis B, Chronic/ethnology ; Hepatitis B, Chronic/virology ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; ROC Curve ; Random Allocation ; Risk Assessment
Czasopismo naukowe
Tytuł :
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liao SH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University Cancer Center, Taipei, Taiwan.
Hong CM; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Adhoute X; Department of Hepato-Gastroenterology, Hôpital Saint Joseph, Marseille, France.
Bourlière M; Department of Hepato-Gastroenterology, Hôpital Saint Joseph, Marseille, France.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2019 Dec; Vol. 34 (12), pp. 2179-2186. Date of Electronic Publication: 2019 Jun 18.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Severity of Illness Index*
Carcinoma, Hepatocellular/*diagnosis
Liver Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/therapy ; Chemoembolization, Therapeutic/methods ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Neoplasm Staging ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Taiwan/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
High Level of Hepatitis B Core-Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load.
Autorzy :
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Hsu CY; Graduate Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Hong CM; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Division of Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang HC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Huang YT; Institute of Statistical Science, Academia Sinica, Taipei, Taiwan.
Fang-Tzu Kuo S; Royal Hobart Hospital, Hobart, Australia.
Liu CH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Kao JH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2019 Dec; Vol. 157 (6), pp. 1518-1529.e3. Date of Electronic Publication: 2019 Aug 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*epidemiology
Hepatitis B Antigens/*blood
Hepatitis B virus/*isolation & purification
Hepatitis B, Chronic/*complications
Liver Neoplasms/*epidemiology
Adult ; Biomarkers/blood ; Carcinoma, Hepatocellular/virology ; DNA, Circular/blood ; DNA, Viral/blood ; Female ; Follow-Up Studies ; Hepatitis B virus/immunology ; Hepatitis B, Chronic/blood ; Hepatitis B, Chronic/virology ; Humans ; Incidence ; Liver Neoplasms/virology ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Taiwan/epidemiology ; Viral Load
Czasopismo naukowe
Tytuł :
Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.
Autorzy :
Xu LX; Departments of Gastroenterology and Hepatology.
He MH; Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Dai ZH; Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Yu J; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong.
Wang JG; State Key Laboratory of Molecular Neuroscience, Division of Life Science, Department of Chemical and Biological Engineering, Center of Systems Biology and Human Health, The Hong Kong University of Science and Technology, Hong Kong.
Li XC; Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin Cancer Institute, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin.
Jiang BB; State Key Laboratory of Molecular Neuroscience, Division of Life Science, Department of Chemical and Biological Engineering, Center of Systems Biology and Human Health, The Hong Kong University of Science and Technology, Hong Kong.
Ke ZF; Departments of Pathology.
Su TH; Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Peng ZW; Oncology.
Guo Y; Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen ZB; Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen SL; Division of Interventional Ultrasound.
Peng S; Departments of Gastroenterology and Hepatology; Clinical Trials Unit, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address: .
Kuang M; Liver Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China; Division of Interventional Ultrasound. Electronic address: .
Pokaż więcej
Źródło :
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2019 Jun 01; Vol. 30 (6), pp. 990-997.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
Carcinoma, Hepatocellular/*genetics
Genomics/*methods
Liver Neoplasms/*genetics
Biomarkers, Tumor/genetics ; Carcinoma, Hepatocellular/classification ; Carcinoma, Hepatocellular/pathology ; Clonal Evolution ; DNA Copy Number Variations ; Genetic Heterogeneity ; Humans ; Liver Neoplasms/classification ; Liver Neoplasms/pathology ; Phylogeny ; Prognosis ; Tumor Microenvironment ; Whole Exome Sequencing/methods
Czasopismo naukowe
Tytuł :
Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
Autorzy :
Liu CJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang HC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Liu CH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2019 Feb; Vol. 34 (2), pp. 410-417. Date of Electronic Publication: 2018 Sep 20.
Typ publikacji :
Journal Article
MeSH Terms :
Coinfection*
Health Status Indicators*
Carcinoma, Hepatocellular/*epidemiology
Hepatitis B, Chronic/*diagnosis
Hepatitis C, Chronic/*diagnosis
Liver Cirrhosis/*epidemiology
Liver Neoplasms/*epidemiology
Adult ; Antiviral Agents/therapeutic use ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/virology ; Female ; Health Status ; Hepatitis B, Chronic/drug therapy ; Hepatitis B, Chronic/epidemiology ; Hepatitis B, Chronic/virology ; Hepatitis C, Chronic/drug therapy ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/virology ; Humans ; Incidence ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/virology ; Liver Neoplasms/diagnosis ; Liver Neoplasms/virology ; Male ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Sustained Virologic Response ; Taiwan/epidemiology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma.
Autorzy :
Liao SH; National Taiwan University Cancer Center, Taipei, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Jeng YM; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
Liang PC; Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Chen CH; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan.; National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Hepatology (Baltimore, Md.) [Hepatology] 2019 Jan; Vol. 69 (1), pp. 209-221.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*mortality
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*mortality
Liver Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma.
Autorzy :
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital Jinshan Branch, New Taipei City, Taiwan.; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Su TH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Yang WT; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Yang HC; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Microbiology, National Taiwan University College of Medicine, Taipei, Taiwan.
Wang CC; Division of Gastroenterology, Department of Internal Medicine, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan.; School of Medicine, Tzu Chi University, Hualien, Taiwan.
Kuo SF; Genomics Research Center Academia Sinica, Taipei City, Taiwan.
Liu CH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Chen DS; St Vincent's Hospital, Melbourne, Victoria, Australia.
Kao JH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
The American journal of gastroenterology [Am J Gastroenterol] 2017 Oct; Vol. 112 (10), pp. 1564-1574. Date of Electronic Publication: 2017 Aug 29.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular*/diagnosis
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/pathology
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/drug therapy
Hepatitis B, Chronic*/epidemiology
Liver Cirrhosis*/diagnosis
Liver Cirrhosis*/etiology
Liver Cirrhosis*/pathology
Liver Neoplasms*/diagnosis
Liver Neoplasms*/epidemiology
Liver Neoplasms*/pathology
Adult ; Antiviral Agents/therapeutic use ; Biomarkers/analysis ; Female ; Follow-Up Studies ; Health Status Indicators ; Humans ; Liver Function Tests/methods ; Male ; Middle Aged ; Predictive Value of Tests ; Risk Assessment ; Risk Factors ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.
Autorzy :
Dela Rosa MA
Chen WC; Department of Chemistry, National Taiwan Normal University , Taipei, Taiwan.
Chen YJ
Obena RP
Chang CH
Capangpangan RY; Caraga State University , Butuan City, Philippines.
Su TH
Chen CL
Chen PJ
Chen YJ
Pokaż więcej
Źródło :
Analytical chemistry [Anal Chem] 2017 Apr 04; Vol. 89 (7), pp. 3973-3980. Date of Electronic Publication: 2017 Mar 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*blood
Carcinoma, Hepatocellular/*blood
Glycoproteins/*blood
Liver Neoplasms/*blood
Nanoparticles/*chemistry
Antibodies/chemistry ; Antibodies/metabolism ; Biomarkers, Tumor/metabolism ; Chromatography, Liquid ; Enzyme-Linked Immunosorbent Assay ; Glycoproteins/metabolism ; Humans ; Lectins/chemistry ; Lectins/metabolism ; Magnetite Nanoparticles/chemistry ; Protein Processing, Post-Translational ; Silicon Dioxide/chemistry ; Silicon Dioxide/metabolism ; Tandem Mass Spectrometry
Czasopismo naukowe
Tytuł :
Surveillance of Hepatocellular Carcinoma by Magnetic Resonance Imaging With Liver-Specific Contrast.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan2Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan2Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2017 Apr 01; Vol. 3 (4), pp. 446-447.
Typ publikacji :
Journal Article; Comment
MeSH Terms :
Carcinoma, Hepatocellular*
Liver Cirrhosis*
Liver Neoplasms*
Humans ; Magnetic Resonance Imaging
Czasopismo naukowe
Tytuł :
Early Response of Hepatocellular Carcinoma to Chemoembolization: Volume Computed Tomography Liver Perfusion Imaging as a Short-Term Response Predictor.
Autorzy :
Su TH; From the Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Xicheng District, Beijing, China.
He W
Jin L
Chen G
Xiao GW
Pokaż więcej
Źródło :
Journal of computer assisted tomography [J Comput Assist Tomogr] 2017 Mar/Apr; Vol. 41 (2), pp. 315-320.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular/*diagnostic imaging
Carcinoma, Hepatocellular/*therapy
Chemoembolization, Therapeutic/*methods
Liver Neoplasms/*diagnostic imaging
Liver Neoplasms/*therapy
Multidetector Computed Tomography/*methods
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Liver/diagnostic imaging ; Male ; Middle Aged ; Predictive Value of Tests ; Prospective Studies ; Retrospective Studies ; Tomography, Spiral Computed/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Autorzy :
Su TH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Kao JH; Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2017 Feb; Vol. 37 (2), pp. 310-311.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Carcinoma, Hepatocellular*
Hepatitis B, Chronic*
Antiviral Agents ; DNA, Viral ; Guanine/analogs & derivatives ; Hepatitis B virus/genetics ; Humans ; Liver Cirrhosis ; Liver Neoplasms
Raport
Tytuł :
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients.
Autorzy :
Su TH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Hu TH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Chen CY; Department of Internal Medicine, Chia-Yi Christian Hospital, Chiayi, Taiwan.
Huang YH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Chuang WL; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin CC; Division of Gastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Wang CC; Division of Gastroenterology, Department of Internal Medicine, Taipei Tzuchi Hospital, the Buddhist Tzuchi Medical Foundation, Taipei, Taiwan.
Su WW; Department of Gastroenterology and Hepatology, Changhua Christian Hospital, Changhua, Taiwan.
Chen MY; Department of Internal Medicine, Shuang-Ho Hospital, Taipei Medical University, Taipei, Taiwan.
Peng CY; Division of Hepatogastroenterology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Chien RN; Liver Research Unit, Chang Gung Memorial Hospital, Keelung, Taiwan.
Huang YW; Liver Center, Cathay General Hospital Medical Center, Taipei, Taiwan.
Wang HY; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Lin CL; Department of Gastroenterology, Ren-Ai Branch, Taipei City Hospital, Taipei, Taiwan.
Yang SS; Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chen TM; Division of Hepato-Gastroenterology, Department of Internal Medicine and Department of Medical Research, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan.
Mo LR; Department of Internal Medicine, Tainan Municipal Hospital, Tainan, Taiwan.
Hsu SJ; Department of Internal Medicine, National Taiwan University Hospital, Yun-Lin Branch, Yunlin, Taiwan.
Tseng KC; Department of Hepatology, Buddhist Tzu Chi General Hospital, Da-Lin Branch, Chiayi, Taiwan.
Hsieh TY; Department of Gastroenterology, Tri-service General Hospital, Taipei, Taiwan.
Suk FM; Division of Gastroenterology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Hu CT; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital and University, Hualien, Taiwan.
Bair MJ; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Mackay Memorial Hospital, Taitung, Taiwan.
Liang CC; Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan.
Lei YC; Department of Family Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Tseng TC; Department of Internal Medicine, National Taiwan University Hospital, Jin-Shan Branch, New Taipei City, Taiwan.
Chen CL; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Kao JH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Corporate Authors :
C-TEAM study group and the Taiwan Liver Diseases Consortium
Źródło :
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2016 Dec; Vol. 36 (12), pp. 1755-1764. Date of Electronic Publication: 2016 Oct 04.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents/*therapeutic use
Carcinoma, Hepatocellular/*epidemiology
Guanine/*analogs & derivatives
Hepatitis B, Chronic/*complications
Hepatitis B, Chronic/*drug therapy
Liver Cirrhosis/*mortality
Liver Neoplasms/*epidemiology
Adult ; Esophageal and Gastric Varices/epidemiology ; Female ; Gastrointestinal Hemorrhage/epidemiology ; Guanine/therapeutic use ; Hepatitis B e Antigens/blood ; Hepatitis B virus/genetics ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Proportional Hazards Models ; Prospective Studies ; Retrospective Studies ; Taiwan ; Treatment Outcome ; alpha-Fetoproteins/analysis
Czasopismo naukowe
Tytuł :
Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.
Autorzy :
Lin WH; Department of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Yeh SH; Department of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University, Taipei 100, Taiwan.
Yeh KH; Department of Oncology, National Taiwan University Hospital, National Taiwan University, Taipei 100, Taiwan.
Chen KW; Department of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Cheng YW; Department of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Su TH; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Jao P; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Ni LC; Department of Microbiology, College of Medicine, National Taiwan University, Taipei 100, Taiwan.
Chen PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan; .
Chen DS; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei 100, Taiwan; Genomics Research Center, Academia Sinica, Taipei 115, Taiwan .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2016 Oct 18; Vol. 113 (42), pp. 11937-11942. Date of Electronic Publication: 2016 Oct 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents/*pharmacology
Carcinoma, Hepatocellular/*etiology
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*etiology
Liver Neoplasms/*pathology
Trans-Activators/*genetics
Triazines/*pharmacology
Animals ; Biomarkers ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/therapy ; Cell Line, Tumor ; Combined Modality Therapy ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Hepatic Artery/surgery ; Humans ; Immunohistochemistry ; Ligation ; Liver Neoplasms/therapy ; Magnetic Resonance Imaging ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Mice, Transgenic ; Necrosis ; Recurrence ; Tirapazamine ; Tumor Burden/drug effects ; Viral Regulatory and Accessory Proteins ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model.
Autorzy :
Li YT; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Liu CJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Su TH; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Cheng HR; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jeng YM; Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan.
Lin HL; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Wang CC; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Kao JH; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen PJ; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Chen DS; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Wu HL; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2016 Jul 26; Vol. 7 (30), pp. 47173-47185.
Typ publikacji :
Journal Article
MeSH Terms :
Marmota*
Antigens, Neoplasm/*metabolism
Carcinoma, Hepatocellular/*metabolism
Liver Neoplasms/*metabolism
NF-kappa B/*metabolism
Trans-Activators/*metabolism
Amino Acid Sequence ; Animals ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; Disease Models, Animal ; Disease Progression ; Female ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Signal Transduction ; Transfection ; Viral Regulatory and Accessory Proteins
Czasopismo naukowe
Tytuł :
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis.
Autorzy :
Yang HI; Genomics Research Center, Academia Sinica, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, Taipei Tzuchi Hospital, Taipei, Taiwan; School of Medicine, Tzu Chi University, Hualien, Taiwan.
Liu J; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Lee MH; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.
Liu CJ; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, and Hepatitis Research Center, National Taiwan University, Taipei, Taiwan.
Su TH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, and Hepatitis Research Center, National Taiwan University, Taipei, Taiwan.
Batrla-Utermann R; Roche Diagnostics Ltd, Switzerland.
Chan HL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong. Electronic address: .
Kao JH; Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, and Hepatitis Research Center, National Taiwan University, Taipei, Taiwan; Department of Medical Research, National Taiwan University College of Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: .
Chen CJ; Genomics Research Center, Academia Sinica, Taipei, Taiwan; Graduate Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2016 Mar; Vol. 14 (3), pp. 461-468.e2. Date of Electronic Publication: 2015 Nov 18.
Typ publikacji :
Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*diagnosis
DNA, Viral/*blood
Hepatitis B Surface Antigens/*blood
Hepatitis B, Chronic/*complications
Hepatitis B, Chronic/*pathology
Serum/*chemistry
Adult ; Aged ; Female ; Hong Kong ; Hospitals, University ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/pathology ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Risk Assessment ; Taiwan
Czasopismo naukowe
Tytuł :
Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.
Autorzy :
Yang WT; From the Division of Gastroenterology (T-CT, C-CW), Department of Internal Medicine, Taipei Tzuchi Hospital, The Buddhist Tzuchi Medical Foundation; Division of Gastroenterology (H-CY, T-HS, C-HL, P-JC, C-JL, J-HK), Department of Internal Medicine; Graduate Institute of Clinical Medicine (C-LC, T-HS, C-HL, C-JL, J-HK); Hepatitis Research Center (W-TY, C-HL, J-HK); Department of Medical Research (J-HK); Department of Microbiology (H-CY), National Taiwan University College of Medicine and National Taiwan University Hospital; Master of Public Health Degree Program (W-TY), National Taiwan University, Taipei; Division of Gastroenterology (L-WW), Department of Internal Medicine, Taipei Medical University-Shuang Ho Hospital, New Taipei; School of Medicine (T-CT, C-CW), Tzu Chi University, Hualien; Genomics Research Center Academia Sinica (D-SC), Taipei, Taiwan; St Vincent's Hospital (SF-TK), Melbourne VIC, Australia; and Taiwan Liver Disease Consortium (TLC) (C-JL), Taipei, Taiwan.
Wu LW
Tseng TC
Chen CL
Yang HC
Su TH
Wang CC
Kuo SF
Liu CH
Chen PJ
Chen DS
Liu CJ
Kao JH
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2016 Mar; Vol. 95 (10), pp. e2995.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Forecasting*
Carcinoma, Hepatocellular/*immunology
Hepatitis B/*immunology
Hepatitis B Surface Antigens/*immunology
Hepatitis B virus/*immunology
Hepatitis C/*immunology
Liver Neoplasms/*immunology
Adult ; Aged ; Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/pathology ; Coinfection ; Female ; Follow-Up Studies ; Genotype ; Hepacivirus/genetics ; Hepacivirus/immunology ; Hepatitis B/complications ; Hepatitis B/virology ; Hepatitis B virus/genetics ; Hepatitis C/complications ; Hepatitis C/virology ; Hepatitis C Antigens/immunology ; Humans ; Liver Neoplasms/etiology ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Prognosis ; RNA, Viral/analysis ; Retrospective Studies ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers.
Autorzy :
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital Taipei Branch, New Taipei, Taiwan.
Liu CJ
Chen CL
Yang HC
Su TH
Wang CC
Yang WT
Kuo SF
Liu CH
Chen PJ
Chen DS
Kao JH
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2013 Aug 15; Vol. 208 (4), pp. 584-93. Date of Electronic Publication: 2013 May 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carrier State*
Biomarkers/*blood
Carcinoma, Hepatocellular/*epidemiology
Hepatitis B/*complications
Hepatitis B Surface Antigens/*blood
Hepatitis B e Antigens/*blood
Liver Neoplasms/*epidemiology
Adult ; Aged ; DNA, Viral/blood ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Risk Assessment ; Taiwan/epidemiology ; Viral Load
Czasopismo naukowe
Tytuł :
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
Autorzy :
Tseng TC; Division of Gastroenterology, Department of Internal Medicine, Buddhist Tzu Chi General Hospital Taipei Branch, Taipei, Taiwan.
Liu CJ
Yang HC
Su TH
Wang CC
Chen CL
Kuo SF
Liu CH
Chen PJ
Chen DS
Kao JH
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2012 May; Vol. 142 (5), pp. 1140-1149.e3; quiz e13-4. Date of Electronic Publication: 2012 Feb 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular/*etiology
Hepatitis B Surface Antigens/*analysis
Hepatitis B, Chronic/*complications
Liver Neoplasms/*etiology
Adult ; Aged ; Alanine Transaminase/blood ; Carcinoma, Hepatocellular/virology ; DNA, Viral/analysis ; Female ; Hepatitis B e Antigens/analysis ; Humans ; Liver Neoplasms/virology ; Male ; Middle Aged ; Risk Factors ; Viral Load
Czasopismo naukowe
    Wyświetlanie 1-19 z 19

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies